Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice
about
Animal and in silico models for the study of sarcomeric cardiomyopathiesTargets for therapy in sarcomeric cardiomyopathiesMybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in miceMYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correctionPrevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice.Epigallocatechin-3-Gallate Accelerates Relaxation and Ca2+ Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice.FHL2 expression and variants in hypertrophic cardiomyopathy.INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy-a Randomised Intervention Trial with losartan)In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in Duchenne muscular dystrophyAntisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy.Therapeutic activity of modified U1 core spliceosomal particlesSplice-switching antisense oligonucleotides as therapeutic drugsMYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutationAlterations in sarcomere function modify the hyperplastic to hypertrophic transition phase of mammalian cardiomyocyte development.Missing links in cardiology: long non-coding RNAs enter the arena.Development of therapeutic splice-switching oligonucleotides.In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs.I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model.The Role of Cardiac Myosin Binding Protein C3 in Hypertrophic Cardiomyopathy-Progress and Novel Therapeutic Opportunities.Welcome to the splice age: antisense oligonucleotide-mediated exon skipping gains wider applicability.Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes.Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model.Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy.Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.Activation of Autophagy Ameliorates Cardiomyopathy in Mybpc3-Targeted Knockin Mice.Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathy.RNA-Seq Analysis of an Antisense Sequence Optimized for Exon Skipping in Duchenne Patients Reveals No Off-Target Effect.Genome Editing in Cardiovascular Biology.Gene Editing and Gene-Based Therapeutics for Cardiomyopathies.Genome Editing Redefines Precision Medicine in the Cardiovascular Field.Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers.S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart TissueChanges in the cardiac metabolome caused by perhexiline treatment in a mouse model of hypertrophic cardiomyopathy
P2860
Q26865437-3A3B7602-007E-4215-A3D5-2224C89E2F49Q27027023-4042DDA3-304A-4FD5-BE1F-18FA08BB1B54Q28253008-16DE3267-5CD1-4FF6-97D8-3FC493FDE79BQ28304022-39B6A6E0-6E8B-444D-ABE8-C0BCDE391B9BQ30626615-6201CCC5-522C-40B1-BF9C-6C33DBABA57BQ30830714-306944BB-A204-4891-BFED-BA5E73652E2BQ34430364-D5486B4D-780A-451F-B1D5-507CD7850236Q35217983-B64F9A5D-EFE4-481D-A891-6FDBA60F4248Q35588627-01A9800A-1812-46DB-B36E-495173C74A25Q35822565-409A741D-9818-4858-94FB-25634FE1E9E6Q36768787-83734CD3-6903-4BA3-A0DA-F50E2C76E1B1Q37211004-9847C275-D3FE-45B3-A9D5-3A53330E4C66Q37625105-D8AC280F-69F1-46CF-8312-18B3678D575DQ37646848-E0031570-2115-4B0E-A34F-5E82C6668FEBQ38195224-7697CB51-50C5-43E2-BD35-BBE8A2693C6CQ38211673-B1150C0C-F9AB-4EF9-AE4B-34D0AE4C44D7Q38314019-72307EC2-7167-450A-9C9B-4E25333052C9Q38635697-D09383BD-9B3B-4D06-9F7F-866971638F4CQ38978665-2F494B69-3631-4198-9314-B6C3C5D29F1EQ39617548-3314228B-4C71-4FE2-88E0-AAF2FC6B641DQ40156224-7D2609C7-AA13-45BD-910E-B5B41E61BD97Q41203153-F2A72551-8E92-44D1-8606-C39917D8B6FBQ41825817-893A666A-E267-40C2-8DF0-05B9CB2291C5Q42504304-9C959679-CBDC-4C31-9237-887700B9B367Q42515078-A007A838-D4A0-4BA0-A5A5-C189A683A345Q45861345-BA0A10C5-5363-48D4-8EC4-383431F60366Q47665566-199719D7-E8F3-447D-B6B0-52E5F5A7028EQ48747768-445FE085-563D-4262-A13D-3BCDA1B0DD59Q49196789-8836DCF7-9967-4E8C-BDBC-A3C250759246Q52427027-15C08606-869F-4A80-A4B2-0963F99B06E4Q52662536-57809A99-191F-4729-B18F-5E3978D88661Q55012020-65593BE3-B846-42DF-BE2E-288F09C52620Q55496176-569A3901-0F7C-4448-B8D0-DF61AD507B9DQ57072975-E1FC76DA-58A5-4FBB-9FD9-83533C4AEEDDQ57797180-87407F6D-D5BD-4A14-BFB2-6BB1052F4FEA
P2860
Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Rescue of cardiomyopathy throu ...... Mybpc3-targeted knock-in mice
@ast
Rescue of cardiomyopathy throu ...... Mybpc3-targeted knock-in mice
@en
Rescue of cardiomyopathy throu ...... Mybpc3-targeted knock-in mice
@nl
type
label
Rescue of cardiomyopathy throu ...... Mybpc3-targeted knock-in mice
@ast
Rescue of cardiomyopathy throu ...... Mybpc3-targeted knock-in mice
@en
Rescue of cardiomyopathy throu ...... Mybpc3-targeted knock-in mice
@nl
prefLabel
Rescue of cardiomyopathy throu ...... Mybpc3-targeted knock-in mice
@ast
Rescue of cardiomyopathy throu ...... Mybpc3-targeted knock-in mice
@en
Rescue of cardiomyopathy throu ...... Mybpc3-targeted knock-in mice
@nl
P2093
P2860
P50
P3181
P356
P1476
Rescue of cardiomyopathy throu ...... Mybpc3-targeted knock-in mice
@en
P2093
Christina Gedicke-Hornung
Doreen Stimpel
Florian Weinberger
Guillaume Précigout
Luis Garcia
Patrick A Dreyfus
Silke Reischmann
Thomas Eschenhagen
Thomas Voit
Verena Behrens-Gawlik
P2860
P304
P3181
P356
10.1002/EMMM.201202168
P407
P577
2013-07-01T00:00:00Z